Odense University Hospital — Sponsor Intelligence | 51 EU Trials

Filter these 51 trials by condition, phase, country and more.

Open in Search →

51 Registered trials

30 Recruiting

11 Completed trials

12 Countries active

81 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 12 Phase II/III: 2 Phase II: 20 Phase III/IV: 2 Phase IV: 13 Phase I (Other): 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

100%

11 of 11 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Cardiac arrest 2 Chronic kidney disease 2 Type 2 diabetes mellitus 1 Osteopenia 1 Proteinuria 1 Congenital nephrogenic diabetes insipidus 1 Colorectal cancer 1 Pancreatitis chronic 1 Osteoporosis 1

Top IMPs

DAPAGLIFLOZIN 3 HUMAN SERUM ALBUMIN 2 SODIUM CHLORIDE 2 ACETYLSALICYLIC ACID 1 ADRC 1 ADRC001 1 AMILORIDE HYDROCHLORIDE DIHYDRATE 1 ATENOLOL 1 CARVEDILOL 1 CEFUROXIME 1 ELRANATAMAB 1 EMPAGLIFLOZIN 1

All trials — page 2

51 total

FAST TRIAL Recruiting

2024-515507-18-00 Phase III 1 country
What laxatives after hip surgery? Recruiting

2024-513871-42-00 Phase IV 1 country
Self-administration of subcutaneous Elranatamab in the patients’ homes (ERICA) Recruiting

2023-507876-30-00 Phase II 1 country ELRANATAMAB
Intrapleural Fibrinolysis and DNase versus VATS for the treatment of pleural empyema: a randomized, controlled trial Recruiting

2024-513596-40-00 Phase IV 1 country
The effect of oral Semaglutide on bone turnover in patients with T2D: a randomized placebo-controlled clinical trial (SOBER II) Recruiting

2023-505959-45-00 Phase II 1 country TETRACYCLINE HYDROCHLORIDE
CROWD-COMPARE Recruiting

2022-503010-23-01 Phase IV 1 country CARVEDILOL; METOPROLOL SUCCINATE
Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting

2022-502986-92-00 Phase IV 2 countries
Early Initiated Vasopressor Therapy in the Emergency Department - A Multi-center Randomized Controlled Trial (VASOSHOCK) Recruiting

2023-504584-16-00 Phase III 2 countries
Implementation and evaluation of Pressurized Intrathoracic Aerosol Chemotherapy (PITAC) for the treatment of patients with malignant pleural… Recruiting

2023-503297-20-00 Phase I (Other) 1 country
The iCaD Study Recruiting

2022-503026-12-00 Phase III 1 country
An European multinational study of a personalized approach of human albumin administration in patients with cirrhosis of the liver and compl… Recruiting

2022-501006-34-01 Phase III 7 countries HUMAN SERUM ALBUMIN; SODIUM CHLORIDE
Immunotherapy in patients with early dMMR rectal cancer. A Danish DCCG phase II trial Recruiting

2022-500646-14-00 Phase II 1 country IPILIMUMAB; NIVOLUMAB
Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting

2022-500143-21-01 Phase IV 1 country ATENOLOL; DAPAGLIFLOZIN; GLYCERYL TRINITRATE; IOMEPROL; IVABRADINE; METOPROLOL T…
Propofol and Thiopental for intravenous induction in neonates: a dose-finding study (The ProThio Study) Recruiting

2024-516072-15-00 Phase IV 1 country PROPOFOL; THIOPENTAL SODIUM
Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors Recruiting

2024-511601-34-00 Phase IV 1 country
The SABLe study Recruiting

2024-512276-35-00 Phase II 3 countries
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high risk colon cancer patients. - The PIPAC-OPC3 CC trial Ended

2024-519189-31-00 Phase II 1 country
Topical tacrolimus for the amelioration of breast cancer-related lymphedema: a randomized, double-blind, placebo-controlled phase II/III tri… Ended

2023-503644-13-00 Phase III 1 country
SGL-TX-MR Study: The acute effect of SGLT2i on kidney transplant oxygen levels. Ended

2024-513765-40-00 Phase II 1 country EMPAGLIFLOZIN
The SORT OUT XII DAPT Duration Trial Ended

2024-515236-69-00 Phase III/IV 1 country ACETYLSALICYLIC ACID; PRASUGREL
Melatonin for Chronic back pain Ended

2023-503530-41-00 Phase III 1 country MELATONIN
Effect of Camostat for Kidney Protection in Chronic Kidney Disease (CamKid). Ended

2023-508516-34-00 Phase II 1 country
Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease (RIGID Ended

2023-506949-27-00 Phase II 1 country PREDNISOLONE
Treatment of congenital nephrogenic diabetes insipidus with fluconazole an antifungal medication. Ended

2024-517438-16-00 Phase II 1 country

Showing 25–48 of 51 trials

← All sponsors A–Z